Those who suffer from headaches may be more likely to use CAM than others are. Here’s what research shows.
A peculiar pathological presentation within the panorama of neurosyphilis is a phenomenon called meningo-vascu...
Recent research suggests exciting new directions in clinical care and therapeutic development for headache.
Multiple White Matter Hyperintense Lesions
Neurologists, who increasingly will confront patients diagnosed with sports concussion, must be adept at ident...
Of all the bad news physicians give patients, “I’m sorry” seems the most dangerous. Here, we look at how...
History reveals some interesting facts about migraine, perceptions of chronic headaches, and the impact of mig...
News // Pradaxa Gets Green Light
The FDA has approved Pradaxa capsules (dabigatran etexilate, Boehringer Ingelheim) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation). Pradaxa...
Those who suffer from headaches may be more likely to use CAM than others are. Here’s what research shows.
A Q&A with Rebecca E. Wells, MD, MPH
more >
Researchers and clinicians weigh in on the progress and potential of AD biomarker research. more >
Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.